These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 17765985)
1. Statin use in chronic heart failure: waiting for the results of large prospective outcome trials. Celik T; Iyisoy A; Dogru MT; Isik E Int J Cardiol; 2009 Feb; 132(1):122-4; author reply 124-6. PubMed ID: 17765985 [No Abstract] [Full Text] [Related]
2. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias]. Carmena R Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284 [No Abstract] [Full Text] [Related]
3. [Drug of the month. Fluvastatin (Lescol)]. Scheen AJ Rev Med Liege; 1997 Jun; 52(6):442-4. PubMed ID: 9289778 [No Abstract] [Full Text] [Related]
4. Fluvastatin: what is the evidence? Bagg W; Braatvedt G N Z Med J; 1997 Aug; 110(1050):321-2. PubMed ID: 9315035 [No Abstract] [Full Text] [Related]
5. [The hyperlipidemias. Role of various statins]. Farnier M Presse Med; 1999 Nov; 28(36):2002-10. PubMed ID: 10599269 [TBL] [Abstract][Full Text] [Related]
6. Decreased heart rate recovery in patients with heart failure: effect of fluvastatin therapy. Katircibasi MT; Canatar T; Kocum HT; Erol T; Tekin G; Demircan S; Tekin A; Sezgin AT; Baltali M; Muderrisoglu H Int Heart J; 2005 Sep; 46(5):845-54. PubMed ID: 16272775 [TBL] [Abstract][Full Text] [Related]
8. Hydroxymethylglutaryl coenzyme a reductase inhibition: fluvastatin, a clinical investigators' update. Introduction. Brown WV Am J Cardiol; 1994 May; 73(14):1D-2D. PubMed ID: 8198017 [No Abstract] [Full Text] [Related]
9. Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation. Corsini A; Holdaas H Ren Fail; 2005; 27(3):259-73. PubMed ID: 15957541 [TBL] [Abstract][Full Text] [Related]
10. Fluvastatin for lowering cholesterol. Med Lett Drugs Ther; 1994 May; 36(923):45-6. PubMed ID: 8177137 [No Abstract] [Full Text] [Related]
11. Therapeutic impact of statin therapy in patients with low HDL cholesterol. Gotto AM Curr Atheroscler Rep; 1999 Jul; 1(1):1-2. PubMed ID: 11122684 [No Abstract] [Full Text] [Related]
12. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts]. MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509 [No Abstract] [Full Text] [Related]
14. Fluvastatin plus fish oil are more effective on cardiovascular risk factors than fluvastatin alone. Singer P Prostaglandins Leukot Essent Fatty Acids; 2005 May; 72(5):379-80. PubMed ID: 15850720 [No Abstract] [Full Text] [Related]
15. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?]. Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028 [No Abstract] [Full Text] [Related]
16. The Hyperlipidemic Subject with Multiple Risk Factors: A Comprehensive Approach. Proceedings of a symposium. Jerusalem, Israel, September 5, 1993. Am J Med; 1994 Jun; 96(6A):1S-93S. PubMed ID: 7912474 [No Abstract] [Full Text] [Related]
17. [Therapy of atherosclerosis: lipid regulation and direct anti-atherosclerotic effect]. Internist (Berl); 1998 Oct; 39(10 Suppl Lipidregul):1-4. PubMed ID: 9810870 [No Abstract] [Full Text] [Related]
19. Statins or status quo? Baliga RR; Young JB Heart Fail Clin; 2008 Apr; 4(2):ix-xii. PubMed ID: 18433691 [No Abstract] [Full Text] [Related]
20. Revascularization of coronary atherosclerosis in patients with diabetes mellitus--there is more to it than meets the image intensifier. Petersen JL; Harrington RA Am Heart J; 2005 Feb; 149(2):190-3. PubMed ID: 15846254 [No Abstract] [Full Text] [Related] [Next] [New Search]